JPMorgan Chase & Co’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.1K Sell
120
-32,630
-100% -$843K ﹤0.01% 5592
2025
Q1
$334K Sell
32,750
-46,116
-58% -$470K ﹤0.01% 4230
2024
Q4
$1.1M Buy
78,866
+17,979
+30% +$251K ﹤0.01% 3739
2024
Q3
$1.19M Buy
60,887
+40,404
+197% +$788K ﹤0.01% 3556
2024
Q2
$381K Buy
20,483
+20,441
+48,669% +$380K ﹤0.01% 3977
2024
Q1
$589 Hold
42
﹤0.01% 5683
2023
Q4
$357 Sell
42
-2,407
-98% -$20.5K ﹤0.01% 5929
2023
Q3
$21.9K Buy
2,449
+1,974
+416% +$17.6K ﹤0.01% 5132
2023
Q2
$4.1K Sell
475
-15,024
-97% -$130K ﹤0.01% 5307
2023
Q1
$163K Buy
15,499
+2,765
+22% +$29.1K ﹤0.01% 4424
2022
Q4
$433K Sell
12,734
-2,641
-17% -$89.8K ﹤0.01% 3833
2022
Q3
$738K Sell
15,375
-29,063
-65% -$1.4M ﹤0.01% 3550
2022
Q2
$2.53M Buy
44,438
+32,262
+265% +$1.84M ﹤0.01% 2849
2022
Q1
$985K Buy
12,176
+7,564
+164% +$612K ﹤0.01% 3623
2021
Q4
$935K Sell
4,612
-10,941
-70% -$2.22M ﹤0.01% 3730
2021
Q3
$4.19M Sell
15,553
-102
-0.7% -$27.5K ﹤0.01% 2697
2021
Q2
$4.03M Buy
15,655
+647
+4% +$167K ﹤0.01% 2795
2021
Q1
$4.5M Buy
15,008
+3,258
+28% +$978K ﹤0.01% 2718
2020
Q4
$3M Sell
11,750
-2,327
-17% -$594K ﹤0.01% 2725
2020
Q3
$3.57M Sell
14,077
-112
-0.8% -$28.4K ﹤0.01% 2422
2020
Q2
$4.93M Buy
14,189
+1,904
+15% +$661K ﹤0.01% 2161
2020
Q1
$3.29M Sell
12,285
-110,266
-90% -$29.5M ﹤0.01% 2279
2019
Q4
$39.7M Buy
122,551
+7,732
+7% +$2.5M 0.01% 968
2019
Q3
$31.4M Buy
114,819
+14,701
+15% +$4.02M 0.01% 1096
2019
Q2
$52.1M Sell
100,118
-44,917
-31% -$23.4M 0.01% 848
2019
Q1
$73.1M Buy
145,035
+27,414
+23% +$13.8M 0.01% 712
2018
Q4
$58M Buy
117,621
+10,491
+10% +$5.17M 0.01% 756
2018
Q3
$98M Sell
107,130
-35,488
-25% -$32.5M 0.02% 642
2018
Q2
$104M Buy
142,618
+58,157
+69% +$42.6M 0.02% 597
2018
Q1
$135M Sell
84,461
-22,597
-21% -$36M 0.03% 497
2017
Q4
$95.9M Sell
107,058
-47,898
-31% -$42.9M 0.02% 619
2017
Q3
$55M Buy
154,956
+4,703
+3% +$1.67M 0.01% 810
2017
Q2
$44.1M Sell
150,253
-36,908
-20% -$10.8M 0.01% 897
2017
Q1
$65.9M Buy
187,161
+108,256
+137% +$38.1M 0.02% 739
2016
Q4
$14.5M Buy
78,905
+32,173
+69% +$5.92M ﹤0.01% 1476
2016
Q3
$12M Sell
46,732
-11,484
-20% -$2.96M ﹤0.01% 1491
2016
Q2
$12.4M Sell
58,216
-1,260
-2% -$269K ﹤0.01% 1529
2016
Q1
$12.3M Sell
59,476
-8,694
-13% -$1.79M ﹤0.01% 1495
2015
Q4
$17.2M Buy
68,170
+4,490
+7% +$1.13M ﹤0.01% 1283
2015
Q3
$10.5M Sell
63,680
-557
-0.9% -$91.6K ﹤0.01% 1538
2015
Q2
$12.1M Sell
64,237
-238,877
-79% -$44.8M ﹤0.01% 1589
2015
Q1
$50M Sell
303,114
-21,021
-6% -$3.47M 0.01% 841
2014
Q4
$75.4M Buy
324,135
+28,890
+10% +$6.72M 0.02% 694
2014
Q3
$53.5M Buy
295,245
+2,442
+0.8% +$442K 0.01% 791
2014
Q2
$56.3M Sell
292,803
-10,124
-3% -$1.95M 0.01% 782
2014
Q1
$55.1M Buy
302,927
+183,137
+153% +$33.3M 0.02% 742
2013
Q4
$20.4M Sell
119,790
-7,875
-6% -$1.34M 0.01% 1240
2013
Q3
$20M Sell
127,665
-14,120
-10% -$2.21M 0.01% 1260
2013
Q2
$24.6M Buy
+141,785
New +$24.6M 0.01% 1062